课题基金 / 基金详情

UCLA CENTER FOR AIDS RESEARCH (CFAR)

UCLA CENTER FOR AIDS RESEARCH (CFAR)
加州大学洛杉矶分校艾滋病研究中心 (CFAR)
批准号:
6510427
负责人:
IRVIN S.Y. CHEN
金额:
$163.4万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-09-01 至 2003-06-30

项目摘要

项目成果

IRVIN S.Y. CHEN的其他基金

相似基金

相关文献

中文摘要
翻译
这项申请构成了澳大利亚大学的续签申请 加州大学洛杉矶分校(UCLA)申请艾滋病研究中心(CFAR)拨款。 这笔赠款将资助加州大学洛杉矶分校艾滋病中心开展的活动和项目 研究所。加州大学洛杉矶分校艾滋病研究所成立于1992年,旨在协调 大学所有的艾滋病研究、临床和教育活动 和七家附属教学医院隶属于一个中心 行政管理。陈士元博士被任命为创始和现任 艾滋病研究所所长,也是 加州大学洛杉矶分校CFAR。此续订申请包括核心服务和 此处描述的活动旨在促进对 通过基础、临床和行为科学获得艾滋病毒/艾滋病。整体而言 目标是开发治疗方法和方法来预防和最终 消除艾滋病毒/艾滋病的威胁。该研究所由150多名成员组成 负责200多个研究项目的教研员 涵盖艾滋病毒/艾滋病生物学、临床研究和 行为科学调查。加州大学洛杉矶分校一直位居 因其在艾滋病方面的卓越表现而在不同来源排名前五的机构 研究、教育和教学,以及临床项目。大都会洛杉矶 洛杉矶是艾滋病流行的主要震中,也是世界上 国家中文化多元的地区。该研究所的作用是 促进协作并在内部和外部建立联系 上大学。它的重点是创新方法的发展 通过形成多学科协作和提供 通过核心设施向加州大学洛杉矶分校的所有艾滋病研究人员提供关键技术。 此外,该研究所积极主动地提供一名“调查员” 为属于以下范围的外部研究工作提供友好的环境 其宗旨和目标的范围。联盟通过座谈会得到支持, 非正式智库和种子基金。该研究所还致力于确定 并招募新的教员研究员,他们的背景和经验将 加强研究所确定的研究项目 任职人数不足,和/或及时。 请求支助的第一年的行动计划,1998年1月 截至1998年12月,摘要如下。该研究所计划 继续支持最初由以前的 CFAR,行政核心,发育核心,病毒学/BSL3组织 培养核心,流式细胞仪/细胞分选核心,鼠/人嵌合体核心 临床研究核心,基因和细胞治疗核心。在……里面 此外,通过CFAR提供的额外支持,研究所 请求通过Find发起的对两个核心的持续支持 可提供私人筹款努力、粘膜免疫学核心和 生物统计学核心。最后,研究所请求支持三个新的 核心、一个国际核心和两个行为科学核心,以及 坚持艾滋病药物核心,并在行为上坚持,招募 和保持核心,共同构成健康行为和 外展计划。
英文摘要
This application constitutes a renewal on the part of the University of California/Los Angeles (UCLA) for a Center for AIDS Research (CFAR) grant. This grant will fund activities and programs conducted by the UCLA AIDS Institute. The UCLA AIDS Institute was established in 1992 to coordinate all AIDS research, clinical and educational activities at the University and its seven affiliated teaching hospitals under one central administration. Dr. S.Y. Chen was appointed the founding and current Director of the AIDS Institute and is also the Principal Investigator of the UCLA CFAR. This renewal application includes core services and activities described herein that are designed to advance knowledge of HIV/AIDS through the basic, clinical, and behavioral sciences. The overall goal is to develop therapies and approaches to prevent and ultimately eliminate the threat of HIV/AIDS. The Institute consists of more than 150 faculty investigators responsible for over 200 research projects that encompass various aspects of HIV/AIDS biology, clinical studies, and behavioral science investigations. UCLA has consistently been ranked among the top five institutions by various sources for its excellence in AIDS research, education and teaching, and clinical programs. Metropolitan Los Angeles is a major epicenter for the AIDS epidemic and one of the most culturally diverse regions in the nation. The role of the Institute is to foster collaboration and build linkages both within and outside the university. Its emphasis is on the development of innovate approaches through the formation of multidisciplinary collaborations and provision of key technologies through core facilities to all AIDS researchers in UCLA. Additionally, the Institute is proactive in providing an "investigator friendly" environment to external research efforts that fall within the scope of its aims and goals. Alliances are supported through symposia, informal Think Tanks and seed grants. The Institute also works to identify and recruit new faculty investigators whose background and experience will strengthen research programs that the Institute has determine to be underrepresented, and/or timely. The action plan for the first year of requested support, January 1998 through December 1998, is summarized as follows. The Institute plans to continue supporting the seven cores originally funded by the previous CFAR, Administrative Core, Developmental Core, Virology/BSL3 Tissue Culture Core, Flow Cytometry/Cell Sorting Core, Mouse/Human Chimera Core, Clinical Investigations Core, and Gene and Cellular Therapy Core. In addition, through additional support through the CFAR, the Institute requests ongoing support for two cores, initiated through finds made available be private fund-raising efforts, the Mucosal Immunology Core and Biostatistics Core. Finally, the Institute requests support for three new cores, an International Core, and two behavioral science cores, and Adherence to HIV Medication Core, and a Behavioral Adherence, Recruitment and Retention Core, which together comprise the Health Behavior and Outreach Program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
Administrative Core
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
海外基金